The large-conductance, voltage-gated, calcium (Ca 2+ )-activated potassium channel (BK Ca ) plays an important role in regulating Ca 2+ signaling and is implicated in the maintenance of uterine quiescence during pregnancy. We used immunopurification and mass spectrometry to identify proteins that interact with BK Ca in myometrium samples from term pregnant (≥37 wk gestation) women. From this screen, we identified alpha-2-macroglobulin (α 2 M). We then used immunoprecipitation followed by immunoblot and the proximity ligation assay to confirm the interaction between BK Ca and both α 2 M and its receptor, low-density lipoprotein receptor-related protein 1 (LRP1), in cultured primary human myometrial smooth muscle cells (hMSMCs 
The large-conductance, voltage-gated, calcium (Ca 2+ )-activated potassium channel (BK Ca ) plays an important role in regulating Ca 2+ signaling and is implicated in the maintenance of uterine quiescence during pregnancy. We used immunopurification and mass spectrometry to identify proteins that interact with BK Ca in myometrium samples from term pregnant (≥37 wk gestation) women. From this screen, we identified alpha-2-macroglobulin (α 2 M). We then used immunoprecipitation followed by immunoblot and the proximity ligation assay to confirm the interaction between BK Ca and both α 2 M and its receptor, low-density lipoprotein receptor-related protein 1 (LRP1), in cultured primary human myometrial smooth muscle cells (hMSMCs). Single-channel electrophysiological recordings in the cell-attached configuration demonstrated that activated α 2 M (α 2 M*) increased the open probability of BK Ca in an oscillatory pattern in hMSMCs. Furthermore, α 2 M* caused intracellular levels of Ca 2+ to oscillate in oxytocin-primed hMSMCs. The initiation of oscillations required an interaction between α 2 M* and LRP1. By using Ca
2+
-free medium and inhibitors of various Ca 2+ signaling pathways, we demonstrated that the oscillations required entry of extracellular Ca 2+ through store-operated Ca 2+ channels. Finally, we found that the specific BK Ca blocker paxilline inhibited the oscillations, whereas the channel opener NS11021 increased the rate of these oscillations. These data demonstrate that α 2 M* and LRP1 modulate the BK Ca channel in human myometrium and that BK Ca and its immunomodulatory interacting partners regulate Ca 2+ dynamics in hMSMCs during pregnancy.
BK Ca | α2M | LRP1 | myometrial smooth muscle | intracellular calcium D uring pregnancy, the human myometrium remains relatively quiescent until near term, when it becomes more sensitive to contractile stimuli (1) . At term, synchronized phasic contractions develop and increase in strength and frequency to facilitate labor. Phasic contractions require the myometrial smooth muscle cells (MSMCs) to alternate between states of contraction and relaxation. The primary trigger for initiating and maintaining spontaneous contractions is an increase in the intracellular level of the major charge carrier calcium (Ca 2+ ) (2) (3) (4) , which occurs by multiple mechanisms (5, 6) , One, Ca 2+ can enter through voltage-gated channels in response to membrane depolarization. Two, agonist stimulation can cause ligand binding to receptor-operated channels that allow extracellular Ca 2+ to enter the cell to increase intracellular Ca 2+ ([Ca 2+ ] i ). Three, agonist [e.g., oxytocin (OXT)] can bind to receptors that induce Ca 2+ release from intracellular stores, including the sarcoplasmic reticulum, by activating signal transduction pathways (2) . Lastly, store-operated Ca 2+ entry (SOCE) can occur in response to sarcoplasmic reticulum store depletion. The rise in [Ca 2+ ] i activates Ca 2+ -calmodulin, myosin light chain kinase, and the actomyosin machinery, thus leading to MSMC contraction (2, 7).
MSMC relaxation occurs by several mechanisms. First, myosin light chain kinase and myosin light chain phosphatase are inhibited by phosphorylation and dephosphorylation, respectively (8 ] i to basal levels (9) . The predominant K + channel in the myometrium is the largeconductance, voltage-gated, Ca 2+ -activated K + channel (BK Ca ), also known as MaxiK/hSlo/KCa1.1 (10) (11) (12) . Opening of the BK Ca channel provides a strong repolarizing current to maintain MSMCs at a polarized membrane potential, thus preventing voltage-gated Ca 2+ influx and contraction. Conversely, pharmacological block of BK Ca channels depolarizes human MSMCs (hMSMCs), causing activation of voltage-sensitive L-type Ca 2+ channels and increased [Ca 2+ ] i (13) . BK Ca is activated by both depolarization of the plasma membrane and increases in [Ca 2+ ] i (13) . In vascular smooth muscle cells, BK Ca is also activated by Ca 2+ sparks elicited by activation of ryanodine receptors in the sarcoplasmic reticulum (14) , but this mechanism of BK Ca activation does not occur in MSMCs (15) . Although a role for this channel in maintaining the membrane potential in MSMCs, and potentially uterine quiescence, throughout pregnancy is well supported (9, 13, 16) , BK Ca channel protein
Significance
The large-conductance, voltage-gated, calcium (Ca 2+ )-activated potassium channel (BK Ca ) plays an important role in regulating the membrane potential of uterine muscle cells. We demonstrate that BK Ca interacts with the immunomodulator α-2-macroglobulin (α 2 M) and its receptor low-density lipoprotein receptor-related protein 1 in human uterine muscle cells isolated from pregnant women. Furthermore, we report that activated α 2 M regulates BK Ca activity and that activated α 2 M and BK Ca together control Ca 2+ oscillations in the cells, a process dependent on store-operated Ca 2+ entry. This study reveals a previously unidentified modulator of the BK Ca channel and may imply a link between inflammatory processes and excitation changes in the uterine muscle during pregnancy.
expression is lower in myometrial biopsies isolated from women at term than in biopsies obtained from nonpregnant women (17) . Additionally, laboring MSMCs have constitutively active BK Ca channels in the absence of two key channel activators: high levels of Ca 2+ and depolarizing stimuli (18) . These findings indicate that we do not fully understand how BK Ca is regulated throughout pregnancy. One strong possibility is that BK Ca is regulated by association with other proteins. In fact, BK Ca interacts with various plasma membrane and intracellular proteins and acts as a "coordinator" of cell signaling in other tissues (19) (20) (21) (22) (23) . Such interactions add functional diversity to BK Ca and may contribute to its cell-and tissuespecific regulation.
To identify proteins that interact with BK Ca in human myometrium during pregnancy and assess their roles in uterine excitability, we affinity-purified BK Ca channels from myometrium isolated from women at term and performed a proteomic analysis of the interacting proteins. We focused on a strong "hit" from this screen, the pan-proteinase inhibitor α-2-macroglobulin (α 2 M), for three reasons: (i) α 2 M plasma levels rise consistently and significantly increase during pregnancy (24); (ii) α 2 M regulates cytokine production, which has been implicated in preterm and term labor (25) ; and (iii) α 2 M is important for other aspects of pregnancy, including embryo implantation, in the mouse (26) . However, α 2 M's role in human pregnancy and labor is not yet known. In its inactive form, α 2 M can bind to certain cytokines or proteases, leading to proteolytic digestion of the "bait" region of α 2 M and trapping of the cytokine/proteases. The proteolytic digestion conformationally changes α 2 M to its active form (α 2 M*), a state in which it can inhibit the bound endoprotease. This change also exposes the receptor recognition site/epitope for high-affinity binding to the α 2 M* receptor, low-density lipoprotein receptorrelated protein 1 (LRP1) [reviewed in Rehman et al. (27) ]. Binding of α 2 M* to LRP1 initiates endocytosis of the cytokine/ protease-α 2 M*-LRP1 complex, mediating the clearance of cytokines/proteases (28, 29) , and also leads to an increase in [Ca 2+ ] i (30) . Several cell types secrete α 2 M, and, given its regulation by multiple factors, including cytokines and hormones (24) ] i dynamics provide evidence that immune-modulating signaling pathways interact with controllers of myometrial excitability.
Materials and Methods
Tissue Samples. Human myometrial tissue samples from the lower uterine segment were obtained from nonlaboring women at term (≥37 wk gestation) during elective Cesarean section under spinal anesthesia. The recruited subjects had a history of repeat Cesarean sections with no spontaneous or induced labor. A total number of 105 myometrial biopsies were used for these studies. All subjects signed written consent forms approved by the Washington University in St. Louis Internal Review Board (approval no. 201108143). Tissues were obtained in 0.9% saline solution and processed within 1 h.
Isolation and Primary Culture of hMSMCs. The hMSMCs were isolated and cultured as previously described (31) . Briefly, the tissue was washed twice in cold Dulbecco's PBS containing 50 μg/mL gentamicin and 5 μg/mL Fungizone (both from GIBCO-BRL). The tissue was then cut into 2-to 3-mm pieces, and explants were cultured in DMEM-Ham's F-12 medium supplemented with 5% FBS, 25 μg/mL gentamicin, 2 ng/mL basic FGF, 3 ng/mL EGF (Lonza), 5 μg/mL Fungizone, and 5 μg/mL insulin (Sigma). Once explant colonies formed, they were expanded. For all experiments, hMSMCs were used at passage 1 or 2.
Protein Preparation from Tissues. For total lysate (TL) preparations, human nonlaboring uterine tissue was homogenized in Triton-lysis buffer [1% Triton, 150 mM NaCl, 10 mM Tris (pH 8.0)] plus a complete protease inhibitor tablet (Roche) as previously described (32) , and then spun at 800 × g for 15 min. The supernatant was cleared by spinning at 14,000 × g for 15 min. Isolation of membrane proteins followed the same procedure except that membrane preparation (MP) buffer [250 mM sucrose, 50 mM 3-morpholinopropane-1-sulfonic acid, 2 mM EDTA, 2 mM EGTA (pH 7.4)] was used, and the final supernatant was further centrifuged at 54,000 × g for 80 min. The pellet was then resuspended overnight with gentle agitation in 100-200 μL of Triton lysis buffer. All steps were performed at 4°C.
Cross-Linking Abs to Beads. Abs against BK Ca (rabbit polyclonal; Santa Cruz Biotechnology), LRP1 (mouse monoclonal; Santa Cruz Biotechnology), α 2 M (mouse monoclonal, R&D Systems), and rabbit and goat IgG (Sigma) were incubated with protein A/G beads (Santa Cruz Biotechnology) at room temperature for 1 h. The beads were pelleted at 1,000 × g for 2 min at 4°C, washed three times with 0.01 M PBS (pH 7.5), and then incubated in 450 μM disuccinimidyl suberate (DSS; Pierce) in anhydrous dimethyl formamide for 1 h at room temperature. Beads were pelleted, and DSS was quenched by washing the beads in 50 mM Tris·HCl (pH 7.5) for 15 min at room temperature. After washing with 0.01 M PBS, the beads were suspended in 100 μL of 0.01 M PBS containing 0.025% sodium azide.
Affinity Purification and Sample Preparation for MS. Myometrial tissue MP samples (200 μg) were precleared with protein A/G beads for 30 min at room temperature and then incubated with anti-BK Ca -or rabbit IgG-coupled beads overnight at 4°C in immunoprecipitate (IP) buffer [1% Triton X-100, 150 mM NaCl, 10 mM Tris (pH 7.5)] containing 100 mM PMSF. The lysate-Abbead complexes were washed three times with washing buffer [0.5% Triton X-100, 150 mM NaCl, 1 mM EDTA, 50 mM Tris·HCl (pH 7.5)], and the proteinAb complexes were eluted from the beads with a 1 × 100-μL wash of 100 mM Gly (pH 2.5) and 2 × 100-μL washes of 100 mM Gly and 3 M urea (pH 2.5) at room temperature. Samples were neutralized with 1 M Tris at pH 8.0. The samples were dialyzed against 50 mM Tris and 8 M urea (pH 8.5), and bufferexchanged two more times with 400 μL of 50 mM Tris at pH 8.0. Proteins were reduced in 10 mM DTT for 1 h at 37°C, alkylated in 55 mM iodoacetamide (Thermo Scientific) for 1 h at room temperature in the dark, and digested overnight with 1 μg of trypsin gold (Promega) in 1 M urea. Each sample was spiked with a tryptic digest of BSA containing iodoacetic acid alkylated Cys residues (Michrom Bioresources) at a ratio of 1:75. Samples were acidified and desalted on Vydac C18 spin-columns (The Nest Group) and subjected to strong-cation exchange (SCX) fractionation on polysulfoethyl-A packed spin columns (The Nest Group) according to the manufacturer's protocol. Briefly, desalted samples were dissolved into SCX buffer A [5 mM KHPO 4 , 25% acetonitrile (ACN)] and loaded onto SCX spin-columns, and the tryptic digests were released from the SCX spin-columns by a three-step (20 mM, 40 mM, 60 mM) KCl elution gradient made from a mixture of SCX buffer A and SCX buffer B (5 mM KHPO 4 , 25% ACN, 350 mM KCl). Salt-bumped eluted fractions were desalted on C18 microspin-columns (The Nest Group), dried down, and dissolved into MS loading buffer (1% acetic acid, 1% ACN).
MS. Samples were subjected to liquid chromatography/tandem MS (LC-MS/ MS) on an Agilent 6520 Accurate-Mass Quadropole Time-of-Flight mass spectrometer (Agilent Technologies) interfaced with an HPLC Chip Cube. The samples were loaded onto the large-capacity C18 Chip II (160-nL enrichment column, 9-mm analytical column) and subjected to LC-MS/MS analysis using a 60-min gradient from 1.5% to 35% buffer B (100% ACN, 0.8% acetic acid). The data-dependent settings (MS/MS) included a maximum of 10 ions per cycle at medium isolation width [∼4 atomic mass units (AMU)], and precursor masses were dynamically excluded for 30 s after five MS/MS in a 30-s time window. MS capillary voltage and temperature settings were set to 1,800 V and 330°C, respectively.
Data Analysis-Spectrum Mill Analysis. The raw.d files were searched against the UniProt human database using Spectrum Mill software, version B.04.00.127 (Agilent Technologies) with the following settings: precursor mass tolerance of 50 ppm, product mass tolerance of 300 ppm, and a maximum of two trypsin miscleavages. The search modifications included a static carbamidomethylation on Cys residues (C = 57.02146 AMU) and the following posttranslational modifications: oxidized methionine (M = 15.9949 AMU), phosphorylated Ser, Thr, and Tyr (STY = 79.9663 AMU), and ubiquitinated Lys (K = 114.0429 AMU).
Coimmunoprecipitation for Western Blotting. MP and TL protein samples (200 μg) in 200 μL of IP buffer [10 mM Tris, 150 mM NaCl, 1% Triton X-100, 1 mM PMSF (pH 7.5)] were preadsorbed to 40 μL of Protein A/G beads for 30 min at 4°C. The preadsorbed samples were then incubated with 60 μL of Ab crosslinked beads overnight at 4°C with gentle agitation. The beads were pelleted at 1,200 × g for 2 min at 4°C, washed for 3 × 5 min with Wash Buffer-A [0.5% Triton X-100,150 mM NaCl, 50 mM Tris·HCl, 1 mM EDTA (pH 7.5)], and eluted with 80 μL of 2× SDS buffer (for BK Ca and α 2 M Abs) or 100 mM Gly at pH 2.5 (for LRP1 Ab). Samples were resolved on 4-15% gradient gels and transferred to nitrocellulose membranes. Blots were blocked in 5% (wt/vol) nonfat dry milk in TBS-Tween 20 and probed with Abs against LRP1 (1:400) or α 2 M (1:1,500) in blocking buffer overnight at 4°C. Blots were washed in TBSTween at room temperature, probed with secondary anti-mouse or anti-goat Abs (1:10,000; Jackson Immunoresearch) for 1 h at room temperature, and developed with enhanced chemiluminescence (Denville Scientific Inc.).
In Situ Proximity Ligation Assay. The hMSMCs were cultured in chambered slides (eight-well; LabTek), serum-deprived in 0.5% FBS for 24 h, washed with ice-cold PBS, and then fixed in 4% (wt/vol) paraformaldehyde (PFA) in PBS for 30 min at room temperature with gentle rocking. After 3 × 5-min washes in 0.01 M PBS, cells were permeabilized with 0.1% Triton X-100 for 15 min at room temperature, washed twice with PBS, and washed once in PBS containing 100 mM Gly to quench residual PFA. The slides were rinsed in milliQ water to remove residual salts, and in situ proximity ligation assay (PLA; Duolink PLA; Olink Biosciences) labeling was performed with Abs against the following proteins: BK Ca , β1 (rabbit polyclonal; Abcam), α 2 M, LRP1, and the small-conductance Ca 2+ -activated K + channel (SK3, rabbit monoclonal; Alomone Labs) (all diluted 1:100 except for LRP1, which was diluted 1:250). The manufacturer's protocol was followed exactly except that the cells were stained with nuclear dye TOPRO 3-iodide (1:1,000; Invitrogen) for 5 min at room temperature before the final wash in wash buffer B. Slides were dried at room temperature in the dark, mounted in Vectashield (Vector Laboratories), and stored in the dark at −20°C until they were analyzed by confocal microscopy (FV500; Olympus). PLA signals were detected at 563 nm, and TOPRO 3-iodide was detected at 633 nm. Duolink ImageTool software (Olink Biosciences) was used for analysis. For accuracy of the quantitation, in certain images, clustered nuclei or nonspecific pixels outside the cells' boundary were digitally removed before analysis. All data are presented as mean ± SEM.
Activation of α 2 M. For some experiments, α 2 M (Sigma) was activated by incubation in 100 mM methylamine (Sigma) in 0.01 M PBS (pH 7.5) for 1 h at room temperature. Activated α 2 M (α 2 M*) was then dialyzed in at least three changes of PBS over 24 h at 4°C as described previously (30) . Inactive α 2 M was processed identically except that methylamine was excluded. For other experiments, α 2 M* was purchased from BioMac (no. 05-04). No differences in Ca 2+ imaging data or patch-clamp recordings were observed between these two sources of α 2 M*.
Electrophysiology. Whole-cell patch-clamp recordings were performed on hMSMCs at room temperature in a bath solution containing 135 mM NaCl, 4.7 mM KCl, 5 mM Hepes, 10 mM glucose, 1 mM MgCl 2 , and 2 mM Ca 2+ (pH 7.4); the pipette solution contained 140 mM KCl, 0.5 mM MgCl 2 , 10 mM Hepes, 1 mM EGTA, and 5 mM Mg-ATP (pH 7.2). Currents were elicited with 20-mV steps (100 ms) from −100 mV to +100 mV, from a holding potential of −80 mV, and were acquired at a sampling rate of 1 kHz using an Axopatch 200B amplifier and pCLAMP software (Molecular Devices). Currents were recorded, in the same cell, in the presence of 350 nM α 2 M and after superfusion with 350 nM α 2 M* for 3 min. Current densities (picoamperes/ picofarads) were plotted as a function of membrane potential.
Single-channel recordings in the cell-attached configuration were performed at room temperature on hMSMCs in a bath solution containing 135 mM NaCl, 4.7 mM KCl, 5 mM Hepes, 10 mM glucose, 1 mM MgCl 2 , and 2 mM Ca 2+ (pH 7.4). Pipette solution contained 140 mM KCl, 20 mM KOH, 2 mM MgCl 2 , and 10 mM Hepes (pH 7.2). Single-channel currents were recorded for 20 min before adding 100 nM OXT; then, after 10 min, either 350 nM α 2 M or α 2 M* was added to the recording chamber, and currents were acquired for at least another 30 min. A holding potential of +100 mV was maintained during the whole experiment. Recordings were acquired at 100 kHz and filtered at 5 kHz. Open probability (P o ), open dwell-time, and single-channel conductance were calculated for each condition using pCLAMP software (Molecular Devices).
Ca
2+ Imaging. The hMSMCs were loaded with 4 μM Fura-2-AM (Teflabs) and 0.1% Pluronic F-127 (Invitrogen) for 30 min at room temperature in the dark in the following buffer: 140 mM NaCl, 5.4 mM KCl, 0.8 mM MgCl 2 , 1.8 mM CaCl 2 , 10 mM NaOH, 10 mM Gly, 10 mM Hepes, 5.5 mM glucose, and 1.1 mM Na 2 HPO 4 (pH 7.4). Cells were then washed with buffer devoid of fluorophore and incubated for an additional 40 min at room temperature to allow de-esterification of Fura-2-AM. The cells were then imaged on an inverted iMIC digital microscope (Till Photonics) using a 20×/0.75 objective (Olympus). The fluorescence excitation was provided by a Polychrome V monochromator (Till Photonics). A CCD camera (Cooke) was used to collect paired images at alternating excitation wavelengths (340/380 nm) through a 510-nm emission filter at 2.608-s intervals. After subtracting the matching background, the image intensities were divided by one another to yield ratio values for individual cells. To identify proteins that interact with BK Ca in myometrium from pregnant women, we generated TLs and MPs from term nonlabor human myometrial tissues and used a BK Ca -specific Ab to affinity purify the BK Ca channel and any interacting proteins. LC-MS/MS analysis of purified samples revealed several proteins known to interact with the BK Ca channel, including the auxiliary β1 subunit, filamin-A, and caveolin-1 (18, 32, 34, 35) . In addition, we identified human α 2 M (UniProt ID no. P01023) as one of the top five multipeptide hits in the screen. Importantly, α 2 M was not detected in negative control samples (tissue purified with IgG). Spectrum Mill software identified eight distinct peptides that covered 5.6% of the α 2 M protein (84 of 1,474 amino acids) and 10 peptides that covered 8.4% of the BK Ca protein ( Table  1 ). The spectrum of the highest intensity α 2 M peptide (MVSGFIPLKPTVK) is shown in Fig. S1 . To confirm the interaction between BK Ca and α 2 M, we first verified that α 2 M is expressed in human myometrial tissues. Reverse transcriptase quantitative PCR analysis revealed that α 2 M, LRP1, and BK Ca mRNAs were all expressed in myometrium samples isolated from term nonlabor and term laboring women. We observed no differences in expression between nonlabor and laboring states (Fig. S2A , list of primers used in Table S1 ). Additionally, immunoblot analysis revealed that α 2 M, but not α 2 M*, protein was present in nonlabor and laboring myometrium (Fig. S2B) . We next examined the TL and MP samples by immunoblot and found that α 2 M was present in both (Fig. 1A, input lanes) . We then immunoprecipitated BK Ca and confirmed by immunoblot that α 2 M coimmunoprecipitated with the BK Ca channel in the MP samples (Fig. 1A , BK Ca lanes). However, very little α 2 M coprecipitated with BK Ca in the TL samples. Finally, we examined LRP1, the receptor through which α 2 M* acts, and found that it was expressed in human myometrium (Fig. 1B, input lanes) and coimmunoprecipitated with the BK Ca channel in both TL and MP samples (Fig. 1B , BK Ca lanes). As expected, immunoprecipitations with anti-α 2 M Ab (Fig. 1A , α 2 M lanes) and anti-LRP1 Abs (Fig. 1B, LRP1 lanes) (Fig. 1  A and B, IgG lanes) .
We further validated these molecular interactions by performing in situ PLAs (36) on hMSMCs. Punctate red fluorescent signals were detected when cells were exposed to Abs specific to BK Ca plus α 2 M or BK Ca plus LRP1 (Fig. 1C) , indicating that these pairs of proteins were located within 40 nM of each other. Signals were not detected in control experiments in which a single Ab was used. As expected, the Ab combinations of BK Ca plus its auxiliary β1 subunit and α 2 M plus LRP1 produced signals (Fig. 1C) . Consistent with the idea that the interaction with LRP1 was specific for the BK Ca channel, PLA using the Ab combination of SK3 channel (another prevalent potassium channel in hMSMCs) and LRP1 produced very few punctae ( Fig.  1 C and D) . Together, these data confirm that α 2 M and LRP1 are expressed in hMSMCs and interact with the BK Ca channel. α 2 M* Increases the P o of BK Ca in hMSMCs. We next evaluated the functional significance of the interaction between BK Ca and α 2 M by performing whole-cell patch-clamp recordings in the presence of inactive or activated α 2 M (α 2 M or α 2 M*, respectively). In this recording configuration, neither α 2 M* nor α 2 M significantly affected the BK Ca current over a voltage range from −100 to +100 mV ( Fig.  2A) . Previous studies have shown that α 2 M* increases [Ca 2+ ] i (30, 37, 38) , a key regulator of the BK Ca channel. Thus, we used the single-channel, cell-attached, patch-clamp configuration, in which cell constituents and signaling pathways are intact, to investigate whether α 2 M* regulates BK Ca activity. Under control conditions, hMSMCs showed low levels of BK Ca channel activity (Fig. 2 B and  C) . To ensure that cells were able to release [Ca 2+ ] i , and thereby promote BK Ca channel activation, cells were superfused with a high dose (100 nM) of the uterotonin OXT. At this dose, OXT increases [Ca 2+ ] i via G protein-coupled receptor activation and release of diacylglycerol and IP 3 , and rapidly desensitizes the OXT receptors (39) . Of the cells tested, 49% (36 of 74 cells from 16 myometrial samples) were sensitive to OXT. In these cells, OXT induced an increase in the P o and dwell-time (from 1.29 to 4.47 ms) of the BK Ca single-channel currents (Fig. 2 B and C) . Treatment of hMSMCs with inactive α 2 M did not alter P o or dwell-time ( Fig. 2B ; 0 of 12 cells from six myometrial samples responded to α 2 M). In contrast, 28% (10 of 36 cells from 16 myometrial samples) of cells responded to application of α 2 M* by increasing both P o and dwell-time of the BK Ca channel openings. However, these increases were oscillatory (19.12 ± 4.85 oscillations per hour; Fig. 2 C-E). These results indicate that α 2 M* activates BK Ca channels, likely through intracellular pathways. ] i in hMSMCs (Fig. S3 and Table S2 ). We first confirmed that the cells were able to respond to OXT, which is known to increase [Ca 2+ ] i . Addition of 100 nM OXT induced a short-duration ( Fig. 3A; 4 ± 1.5 min) single-spike increase in [Ca 2+ ] i in ∼80% (901 of 1,127) of the cells analyzed. Although OXT was present throughout the entire experiment, it did not evoke any further response for up to 100 min. This was likely due to desensitization of the OXT receptor, because a second application of 100 nM OXT failed to produce any increase in [Ca 2+ ] i (Fig. 3A) . When 350 nM α 2 M* was applied after OXT, we observed Ca 2+ oscillations at regular time intervals (Fig. 3B and Table 2 ). Whereas the baseline free [Ca 2+ ] i of the hMSMCs was 20.9 ± 13 nM, the α 2 M*-induced [Ca 2+ ] i peaks were 298 ± 0.08 nM ( Table 2) . We did not observe α 2 M*-induced Ca 2+ oscillations in cells treated with α 2 M* in the absence of OXT (Fig. 3C) .
To determine whether α 2 M* acted through its receptor, LRP1, we pretreated hMSMCs with 500 nM RAP, a competitive antagonist of LRP1. In this case, the amplitude of the initial OXTinduced short-duration increase in [Ca 2+ ] i was reduced and the α 2 M*-induced Ca 2+ oscillations did not occur (Fig. 3D) . Furthermore, inactive α 2 M, which is unable to bind to LRP1, did not induce any change in [Ca 2+ ] i (Fig. 3E) -free buffer). Under these conditions, α 2 M* was unable to produce oscillations, although the OXTelicited peak of [Ca 2+ ] i still occurred (Fig. 4A) . Next, we assessed whether the Ca 2+ entered the cytoplasm through L-type Ca 2+ channels, a major source of Ca 2+ entry in MSMCs; through the sarcoplasmic reticulum; or by SOCE. Treating the cells with the L-type Ca 2+ channel blocker nifedipine did not affect the oscillations (Fig. 4B) . However, α 2 M* was not able to elicit Ca 2+ oscillations when hMSMCs were pretreated with either of two SOCE Whole-cell Cell-attached inhibitors, 40 μM 2-APB or 1 μM BTP2, although the OXT response still occurred (Fig. 4 C and E) . Moreover, adding either 40 μM 2-APB or 1 μM BTP2 after α 2 M*-induced Ca 2+ oscillations were established abolished these oscillations, although the effect of BTP2 was slower than the effect of 2-APB (Fig. 4 D and F) . Finally, blocking IP 3 receptors on the sarcoplasmic reticulum with xestopongin C inhibited both the OXT response and the Ca 2+ oscillations (Fig. 4G) . Together, our data indicate that in hMSMCs primed with OXT, α 2 M*-induced Ca 2+ oscillations require α 2 M* binding to its receptor and influx of extracellular Ca 2+ through SOCs.
BK Ca Activity Modulates the α 2 M*-Induced Ca 2+ Oscillations. In hMSMCs, Ca 2+ influx depolarizes the plasma membrane and activates BK Ca channels to restore the membrane potential. To determine whether BK Ca activity affected the Ca 2+ oscillations, we examined the effect of treating the cells with paxilline, a specific BK Ca channel blocker, or NS11021, a specific BK Ca channel opener. When 500 nM paxilline was added to the cells after establishment of α 2 M*-induced Ca 2+ oscillations, the oscillations were completely abolished ( Fig. 5A and Table 2 ). This result was surprising because we assumed that paxilline would induce depolarization and increase the frequency of the Ca 2+ oscillations. In fact, we observed no change in [Ca 2+ ] i after paxilline was added in the absence of α 2 M* (Fig. 5C ) or in the presence of inactive α 2 M (Fig. S4A) . In contrast, addition of 500 nM NS11021 increased the frequency of the oscillations by twofold (Fig. 5B and Table 2 ). NS11021 did not affect [Ca 2+ ] i in the absence of α 2 M* (Fig. 5D ) or in the presence of inactive α 2 M (Fig. S4B) . To determine whether the Ca 2+ oscillations could be recovered, paxilline was washed out and replaced with buffer containing OXT and α 2 M*. In ∼30% of cells, the Ca 2+ oscillations returned, although they showed reduced amplitude ( Fig. S5 and Table S3 ). Reapplication of OXT plus α 2 M* (in the absence of paxilline) did not affect the already initiated α 2 M*-induced Ca 2+ oscillations (Fig. S5A) .
Discussion BK Ca is the predominant K + channel transcript in human myometrium (10), but its role in regulating uterine contraction is not well understood. In this study, we used an unbiased affinity purification and LC-MS/MS approach to identify proteins that interact with the BK Ca channel in the human myometrium during pregnancy. This approach revealed an interaction between the BK Ca channel and α 2 M. Furthermore, we showed that the BK Ca channel associates with the α 2 M receptor, LRP1, in MSMCs from term pregnant women. Thus, we have identified a previously unknown BK Ca channel complex in hMSMCs that may contribute to regulation of myometrial excitation.
Our observations comparing the effects of α 2 M and α 2 M* lead us to speculate that the BK Ca channel regulates Ca 2+ dynamics only in cells in an inflammatory state. For example, we found that pharmacological inhibition or activation of BK Ca did not affect Ca 2+ dynamics in cells treated with α 2 M but abolished or increased, respectively, the frequency of Ca 2+ oscillations in cells treated with α 2 M*. Furthermore, other studies have shown that paxilline does not affect spontaneous contractions of the uterus (5, 6) . On the basis of our data, we formulated the model illustrated in Fig. 6 . First, OXT, a key uterotonin released in labor and used clinically for labor induction and augmentation (40) , induces an initial rise of [Ca 2+ ] i through activation of IP 3 receptors (Fig. 6A) . Second, LRP1 activation by α 2 M* promotes extracellular Ca 2+ entry via SOCE in conjunction with sarcoplasmic Ca 2+ release and transient activation of BK Ca channels (Fig. 6B) . When BK Ca channels are blocked, K + efflux is prevented, thus lowering the driving force for Ca 2+ influx into the cell (Fig. 6C) . Conversely, pharmacological activation of BK Ca channels facilitates Ca 2+ influx, thereby increasing the frequency (13) . However, we found the opposite: In the presence of α 2 M*, the channel opener NS11021 stimulated Ca 2+ oscillations, creating a potentially procontractile state. At resting potential, BK Ca displays a low open-state probability (32) , and pharmacological block does not alter uterine activity (6) . In light of our findings, we speculate that, depending on the inflammatory state, the BK Ca channel can play two roles in the MSMCs. In a noninflammatory state, BK Ca behaves in a fashion typically noted in excitable cells: The channel is activated at high depolarizing voltages, leading to K + efflux, repolarization of the MSMC membrane, and deactivation of voltage-gated Ca 2+ channels. Conversely, in an inflammatory state, such as we have mimicked with α 2 M*, BK Ca activity can regulate Ca 2+ influx through SOCE to modulate phasic Ca 2+ oscillations. Inhibition of BK Ca inhibits SOCE, and, conversely, BK Ca activation enhances SOCE. These effects appear to be voltage-independent (given the lack of effect of nifedipine) and are more typical of nonexcitable cells than of excitable cells. In the presence of α 2 M*, the effects of paxilline on Ca 2+ oscillations were immediate, suggesting involvement of plasma membrane BK Ca channels. However, our data do not exclude the possibility that (6, 46) . In macrophages, Misra et al. (47) proposed that GRP78, a 78-kDa glucose-regulated protein, is an alternative α 2 M receptor. In the absence of GRP78, α 2 M* was unable to regulate IP 3 and cytosolic free Ca
2+
. GRP78 increases in human myometrium in response to inflammation (48) , is associated with the BK Ca channel in mouse cochlea (49) , and is elevated in labor or preterm labor compared with nonlabor myometrium (48) . We cannot rule out the possibility that GRP78 serves as a receptor for α 2 M*. Nonetheless, our data showed that Ca 2+ influx was inhibited in the presence of RAP, suggesting that LRP1 is the responsible receptor in hMSMCs. Although the identities of the SOCE proteins responsible for α 2 M*-regulated Ca 2+ entry are unknown, evidence from other studies in MSMCs indicate that TRPC (50), STIM, and Orai (51) may contribute to this current. The SOCE blockers 2-APB and BTP2 both inhibit TRPC channels (52) , suggesting that entry through TRPC was, in part, a component of the SOCE entry needed for the Ca 2+ oscillations we observed in the MSMCs. Whether these channels are a functional component of the α 2 M*-LRP1-BK Ca complex will be investigated in future studies.
We found that, in the absence of OXT, α 2 M* failed to produce Ca 2+ oscillations, indicating that the cells must first be primed by Ca 2+ release from the sarcoplasmic reticulum. Further studies will establish whether this stimulus is specific to OXT. Because OXT was present throughout the entire Ca 2+ imaging time, it could be argued that OXT exerted a sustained effect on the cells. However, we did not observe an increase in [Ca 2+ ] i upon a second exposure to OXT, and previous studies have shown that 100 nM OXT desensitizes OXT receptors (39) . Moreover, inactive α 2 M did not induce Ca 2+ oscillations after OXT application. Alternatively, α 2 M* might prevent OXT receptor downregulation through its antiprotease activity. However, we only observed oscillations in the presence of α 2 M*, which is in a locked conformation that cannot bind and clear proteases, thus excluding this possibility (53) . We predict that in hMSMCs, a complex consisting of the OXT receptor, α 2 M*, LRP1, and BK Ca synergistically regulates Ca 2+ dynamics, which, in turn, control excitation-contraction coupling. In support of this idea, previous studies have indicated that LRP1 (54) and the BK Ca channel (32) can localize to specialized lipid-rich membrane domains that facilitate signaling events by positioning functionally interacting molecules in close proximity (55, 56) . Given the physical association between BK Ca , α 2 M*, and LRP1, endocytosis mediated by α 2 M*-LRP1 (57, 58) may result in internalization of BK Ca to decrease membrane localization and may represent another mode of α 2 M* action in MSMCs. This periodic removal of BK Ca from the plasma membrane would provide an excitatory signal to elicit activation of SOCs and Ca 2+ oscillations. Internalization of BK Ca was recently demonstrated in arterial smooth muscle cells; in this case, angiotensin II signaling through PKC stimulated BK Ca channel internalization (59) . Likewise, in cardiomyocytes, ATP-sensitive K + channels are internalized to the endosome, where they serve as a reserve to be trafficked to the surface after cardiac ischemia (60) . Thus, in MSMCs, internalization may provide a mechanism for rapid control of BK Ca channel surface localization to control excitability at the critical juncture between nonlaboring and laboring states.
Data from this and other studies (61) indicate that α 2 M is present in the myometrium; however, we detected the inactive α 2 M form only in native tissue. This could be due to rapid degradation of α 2 M* by the endocytic machinery or destabilization of α 2 M* during sample preparation. Furthermore, we envision that α 2 M* secreted from other tissues, such as the decidua and placenta (24, 62) , might contribute to the response in vivo. Our study indicates that, in addition to its roles in immune cell activation and migration (24) , α 2 M* may affect pregnancy outcomes via cross-talk with the BK Ca channel. We performed our experiments on isolated hMSMCs, but, in vivo, gap junction-mediated connectivity and enhanced intercellular communication of the hMSMCs at the end of pregnancy (63) could magnify α 2 M* action to promote uterine contraction. Both α 2 M* and the BK Ca channel are conserved across species, and α 2 M* is the major endoprotease inhibitor in mammalian blood. However, whether α 2 M* and BK Ca functionally interact in the myometrium of other mammals was not investigated.
In human parturition, an inflammatory process drives cervical ripening and myometrial activation (64), but the process by which inflammation leads to changes in excitability of MSMCs is unclear. Proinflammatory cytokines, such as TNF-α, TGF-β, and IL-1β, have been implicated to be triggers of both term and preterm labor (65) (66) (67) and can bind to and activate α 2 M (24). Thus, we speculate that the proinflammatory state at the time of labor causes α 2 M activation and binding to LRP1, endocytosis of this complex, and an increase in [Ca 2+ ] i , thereby promoting uterine contractility. Moreover, IL-1β, a cytokine important in both term and preterm labor, enhances both basal entry and SOCE, but does not affect L-or T-type voltage-gated Ca 2+ channels (25) . Although the IL-1β-induced increase in [Ca 2+ ] i is likely due, in part, to the IL-1β receptor, additional signaling through the α 2 M* pathway may provide a mechanism for signal enhancement. Inflammation elicited by intrauterine infections can also promote abnormal and premature contractions of the myometrium and preterm labor (68), but whether α 2 M* is responsible for the uterine transition from quiescence to contractility is unclear. Further study to identify and dissect proteins and pathways that regulate ion channel activity to control uterine activity will continue to provide insights into the normal course of pregnancy.
